X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
adult (10) 10
aged (10) 10
female (10) 10
middle aged (10) 10
oncology (10) 10
antineoplastic agents - therapeutic use (6) 6
male (6) 6
dose-response relationship, drug (5) 5
antineoplastic agents - adverse effects (4) 4
antineoplastic agents, phytogenic - administration & dosage (4) 4
breast neoplasms - drug therapy (4) 4
chemotherapy (4) 4
pharmacology & pharmacy (4) 4
antineoplastic agents (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents, phytogenic - adverse effects (3) 3
antineoplastic agents, phytogenic - therapeutic use (3) 3
breast neoplasms - pathology (3) 3
cancer (3) 3
drug administration schedule (3) 3
infusions, intravenous (3) 3
neoplasms - drug therapy (3) 3
paclitaxel - administration & dosage (3) 3
paclitaxel - analogs & derivatives (3) 3
paclitaxel - therapeutic use (3) 3
phase i (3) 3
taxoids (3) 3
adenocarcinoma - drug therapy (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
breast cancer (2) 2
camptothecin (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
chemotherapy, adjuvant (2) 2
clinical-trials (2) 2
colorectal cancer (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - pathology (2) 2
cpt-11 (2) 2
derivatives (2) 2
disease-free survival (2) 2
docetaxel (2) 2
doxorubicin - adverse effects (2) 2
drug evaluation (2) 2
evaluation (2) 2
failure (2) 2
fluorouracil (2) 2
fluorouracil - administration & dosage (2) 2
hematology (2) 2
indoles - adverse effects (2) 2
indoles - pharmacokinetics (2) 2
intoplicine (2) 2
irinotecan (2) 2
leucovorin - administration & dosage (2) 2
life sciences (2) 2
maximum tolerated dose (2) 2
metastasis (2) 2
multicenter (2) 2
nausea - chemically induced (2) 2
neoplasm metastasis (2) 2
neutropenia - chemically induced (2) 2
nsc 645008 (2) 2
paclitaxel - adverse effects (2) 2
pharmacokinetics (2) 2
pharmacology (2) 2
phase i study (2) 2
protein-synthesis inhibitor (2) 2
pyridines - adverse effects (2) 2
pyridines - pharmacokinetics (2) 2
qlq-c30 (2) 2
quality (2) 2
quality of life (2) 2
rp 60475 (2) 2
survival analysis (2) 2
topoisomerase i inhibitors (2) 2
treatment outcome (2) 2
1st-line chemotherapy (1) 1
24-hour infusion (1) 1
3-hour infusion (1) 1
4'-iodo-4'-deoxydoxorubicin (1) 1
5-fluorouracil (1) 1
[ sdv.imm ] life sciences [q-bio]/immunology (1) 1
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (1) 1
abridged index medicus (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - secondary (1) 1
adolescent (1) 1
adriamycin (1) 1
adriamycin cardiotoxicity (1) 1
aged, 80 and over (1) 1
agents (1) 1
agranulocytosis - chemically induced (1) 1
alkaline-medium (1) 1
alkalisches medium (1) 1
alloy (1) 1
alloys (1) 1
alloys:metallic-materials (1) 1
amyloidosis - drug therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/1999, Volume 17, Issue 5, pp. 1413 - 1424
.... Patients and Methods: Patients (n = 392) were randomized to receive either docetaxel 100 mg/m(2) intravenously (IV) every 3 weeks (n = 203... 
THERAPY | ONCOLOGY | DISEASE | PHASE-II | QLQ-C30 | 3-HOUR INFUSION | PACLITAXEL
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/1999, Volume 17, Issue 8, pp. 2341 - 2354
Journal Article
Journal Article
Electroanalysis, ISSN 1040-0397, 08/2014, Volume 26, Issue 8, pp. 1810 - 1815
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 2/2008, Volume 134, Issue 2, pp. 125 - 135
Journal Article
Journal Article
The Oncologist, ISSN 1083-7159, 02/2001, Volume 6, Issue 1, pp. 81 - 91
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/1994, Volume 86, Issue 1, pp. 30 - 33
Intoplicine (RP60475) is the most active analogue evaluated in the 7H-benzo[e]-pyrido-[4,3-b]-indole series of antineoplastic compounds. It exerts its activity... 
Dose-Response Relationship, Drug | Tumor Stem Cell Assay | Humans | Topoisomerase II Inhibitors | Topoisomerase I Inhibitors | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Pyridines - pharmacology | Tumor Cells, Cultured | Antineoplastic agents | Evaluation | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 1999, Volume 35, pp. S194 - S194
Journal Article
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 01/1996, Volume 7, Issue 2, pp. 166 - 174
.... Sixty-nine courses of intoplicine were administered as a 1 h i.v. infusion at dose levels ranging from 12 to 360 mg/m super(2... 
Journal Article
Fundamental and Clinical Pharmacology, ISSN 0767-3981, 1990, Volume 4, Issue 2 S, pp. 197s - 204s
...References Armand JP , De Forni M. , Recondo G. ( 1988 ) Preclinical development and the pharmacokinetics of anticancer drugs . In: Handbook of Chemotherapy... 
toxicity | anticancer drug | cancer | phase I | ethics | CLINICAL-TRIALS | ANTICANCER DRUG | PHARMACOLOGY & PHARMACY | TOXICITY | PHASE-I | CANCER | ETHICS | Ethics, Medical | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - adverse effects | Humans | Drug Evaluation | Antineoplastic Agents - toxicity
Journal Article
European Journal of Cancer, ISSN 0959-8049, 1995, Volume 31, pp. S75 - S76
51 females pts with AR MBC were treated with docetaxel (Taxotere®) at 100 mg/m 2 as a 1-hour IV infusion every 3 week (wks... 
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 427 - 427
Abstract Abstract 427 Introduction: The combination of melphalan and dexamethasone (M-dex... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.